Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

October 13, 2022 updated by: University of Florida

Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation and Disease Activity in Systemic Lupus Erythematosus

This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).

Study Overview

Detailed Description

Given the demonstrated beneficial effects of the Mediterranean dietary pattern in autoimmune disease and the potential benefit of a high-fermented-food diet on inflammatory profiles, we aim to determine the feasibility and relative benefit of a Mediterranean dietary pattern versus a high-fermented-food diet on inflammatory markers and clinical outcomes in individuals with SLE. The primary aim of the study is to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with SLE. Secondary aims will determine the effects of the Mediterranean dietary pattern and a high-fermented-food diet on attenuating inflammation and disease activity in individuals with SLE. This is a 4-month randomized controlled trial with a 1-month baseline of usual diet and 3-month intervention. Participants will complete the online DHQ III and diet adherence questionnaires monthly. Blood will be obtained at randomization and at the end of the intervention period for analysis of inflammatory cytokines. Dietary intake during baseline and intervention will be assessed by 5, ASA 24-h dietary recalls.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Wendy J Dahl, PhD
  • Phone Number: 3522943707
  • Email: wdahl@ufl.edu

Study Contact Backup

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32611
        • Recruiting
        • University of Florida/UF Health
        • Contact:
          • Wendy J Dahl, PhD
          • Phone Number: 352-294-3707
          • Email: wdahl@ufl.edu
        • Contact:
          • Study Coordinator
          • Phone Number: 3522639136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • > 18 years of age
  • Able to provide informed consent and undertake study questionnaire completion in English
  • Meets SLE diagnostic criteria and is currently under the care of a rheumatologist, nephrologist, or other physician regarding SLE care
  • Be willing and able to comply with all the study-related procedures

Exclusion Criteria:

  • Pregnant or planning pregnancy within the duration of the interventional study.
  • Currently following a vegetarian/vegan diet.
  • Allergy/sensitivity to gluten, soy, or cow's milk.
  • Self-disclosure of lactose intolerance
  • Inability to comply with the study procedures.
  • Baseline dietary fiber intake > 30 g/day
  • MEDAS score at baseline > 9
  • Baseline consumption of > 2 servings per day of fermented foods

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mediterranean diet
Participants will receive diet education on adherence to a Mediterranean dietary pattern.
The Mediterranean dietary pattern includes whole or minimally processed foods with a high intake of vegetables, fruits, whole grains, fish, and olive oil.
Experimental: Fermented food
Participants will receive diet education on adherence to a high fermented food dietary pattern.
Fermented foods such as yogurt, kefir, fermented cottage cheese, fermented vegetables, vegetable brine drinks, kombucha, other fermented non-alcoholic drinks, and other foods will be recommended.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence - Mediterranean Diet
Time Frame: baseline, month 1, 2 and 3
Percent of participants achieving 'good to very good adherence') as assessed by the 14-day Mediterranean diet questionnaire (MEDAS) score
baseline, month 1, 2 and 3
Adherence - Fermented Food Diet
Time Frame: baseline, month 1, 2, and 3
Percent of participants achieving > 5 servings of fermented foods per day
baseline, month 1, 2, and 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diet Quality
Time Frame: baseline, month 3
Healthy Eating Index 2015 score (0 minimum to 100 maximum). Higher values indicate better diet quality.
baseline, month 3
Systemic Lupus Erythematosus Disease Activity
Time Frame: baseline, month 3
Systemic Lupus Erythematosus disease activity using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score (0 minimum and 105 maximum, with higher scores representing higher disease activity.
baseline, month 3
ESR
Time Frame: baseline, month 3
Erythrocyte sedimentation rate
baseline, month 3
hsCRP
Time Frame: baseline, month 3
high-sensitivity C-reactive protein
baseline, month 3
anti-dsDNA
Time Frame: baseline, month 3
Anti-double stranded DNA
baseline, month 3
Cytokine profile
Time Frame: baseline, month 3
Cytokines profile e.g., interleukin-18 (IL-18), tumor necrosis factor (TNF), IL-6, IL-2, IL-10
baseline, month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2022

Primary Completion (Anticipated)

May 4, 2025

Study Completion (Anticipated)

May 4, 2025

Study Registration Dates

First Submitted

May 9, 2022

First Submitted That Met QC Criteria

May 13, 2022

First Posted (Actual)

May 18, 2022

Study Record Updates

Last Update Posted (Actual)

October 17, 2022

Last Update Submitted That Met QC Criteria

October 13, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lupus Erythematosus, Systemic

Clinical Trials on Mediterranean Dietary Pattern

3
Subscribe